Solux Co., Ltd. (KOSDAQ:290690)
South Korea · Delayed Price · Currency is KRW 3,450.00
+5.00 (0.15%)
At close: Apr 7, 2026
Solux Revenue
In the year 2025, Solux had annual revenue of 38.27B KRW, down -24.50%. Solux had revenue of 15.46B in the quarter ending December 31, 2025, with 56.67% growth.
Revenue
38.27B
Revenue Growth
-24.50%
P/S Ratio
4.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
168.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.27B | -12.42B | -24.50% |
| Dec 31, 2024 | 50.69B | -9.14B | -15.27% |
| Dec 31, 2023 | 59.83B | 3.93B | 7.03% |
| Dec 31, 2022 | 55.90B | -14.11B | -20.16% |
| Dec 31, 2021 | 70.01B | 12.38B | 21.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dongkuk Industries | 727.76B |
| Powerlogics | 686.53B |
| RedcapTour | 365.55B |
| Intelligent Digital Integrated Security | 327.60B |
| Daihan Pharmaceutical | 208.61B |
| Macrogen | 195.27B |
| Elensys | 69.57B |
| Chemtros | 56.81B |